Recalls & Warnings March 23, 2026 FDA Warns Consumers Not to Use ULTRA ADVANC3 Joint Supplements On February 26, 2026, the FDA warned consumers not to purchase or use ULTRA ADVANC3 and ULTRA ADVANC3 GOLD, products promoted for joint pain relief, because FDA testing found that they contain undeclared dexamethasone, diclofenac, and methocarbamol, which are not permitted in
Long-term safety: Unknown, as few human studies exist
B., Zoricic, I., Sever, M.,
This creates symptoms of aging that include an increase in body fat, loss of libido, muscle mass and bone density, wrinkled skin, thinning hair, and sleep issues, among others
Molecular Weight: Approximately 1419.54 Da
The route prescribed